Cargando…
HDAC pharmacological inhibition promotes cell death through the eIF2α kinases PKR and GCN2
Histone deacetylase inhibitors (HDACi) comprise a family of chemotherapeutic agents used in the clinic to treat cutaneous T-cell lymphoma and tested for the therapy of other malignancies. Previous reports have shown that eIF2α phosphorylation is induced upon treatment with HDACi. However the kinase...
Autores principales: | Peidis, Philippos, Papadakis, Andreas I., Rajesh, Kamindla, Koromilas, Antonis E. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2993797/ https://www.ncbi.nlm.nih.gov/pubmed/21076179 |
Ejemplares similares
-
eIF2α phosphorylation bypasses premature senescence caused by oxidative stress and pro-oxidant antitumor therapies
por: Rajesh, Kamindla, et al.
Publicado: (2013) -
Evidence for eIF2α phosphorylation-independent effects of GSK2656157, a novel catalytic inhibitor of PERK with clinical implications
por: Krishnamoorthy, Jothilatha, et al.
Publicado: (2014) -
Phosphorylation of eIF2α at Serine 51 Is an Important Determinant of Cell Survival and Adaptation to Glucose Deficiency
por: Muaddi, Hala, et al.
Publicado: (2010) -
The eIF2α serine 51 phosphorylation-ATF4 arm promotes HIPPO signaling and cell death under oxidative stress
por: Rajesh, Kamindla, et al.
Publicado: (2016) -
The PERK-eIF2α phosphorylation arm is a pro-survival pathway of BCR-ABL signaling and confers resistance to imatinib treatment in chronic myeloid leukemia cells
por: Kusio-Kobialka, Monika, et al.
Publicado: (2012)